{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T09:09:02Z","timestamp":1790500142903,"version":"4.1.0"},"reference-count":76,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,12,4]],"date-time":"2020-12-04T00:00:00Z","timestamp":1607040000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Iron is both, an essential compound for many metabolic processes, and iron deficiency can impact on the proliferation of cells including lymphocytes but also tumor cells. On the other hand, excess iron-catalyzed radical formation can induce cellular toxicity which has been previously demonstrated for T cells in hereditary iron overload. Despite these interconnections, little is known on the effects of clinically approved intravenous iron supplements for curing cancer-related anemia, on T cell differentiation, tumor proliferation, anti-tumor T cell responses and, of clinical importance, on efficacy of cancer immunotherapies. Herein, we analyzed the effects of intravenous iron supplementation on T cell function and on the effectiveness of anti-cancer chemotherapy with IL-2\/doxorubicin or immunotherapy with checkpoint-inhibitor anti-PD-L1 in C57Bl\/6N female mice with implanted E0771 mammary carcinomas. We found that iron application resulted to an increased availability of iron in the tumor microenvironment and stimulation of tumor growth. In parallel, iron application inhibited the activation, expansion and survival of cytotoxic CD8<jats:sup>+<\/jats:sup> T cells and of CD4<jats:sup>+<\/jats:sup> T helper cells type 1 and significantly reduced the efficacy of the investigated anti-cancer treatments. Our results indicate that iron administration has a tumor growth promoting effect and impairs anti-cancer responses of tumor infiltrating T lymphocytes along with a reduced efficacy of anti-cancer therapies. Iron supplementation in cancer patients, especially in those treated with immunotherapies in a curative setting, may be thus used cautiously and prospective studies have to clarify the impact of such intervention on the outcome of patients.<\/jats:p>","DOI":"10.3389\/fonc.2020.584477","type":"journal-article","created":{"date-parts":[[2020,12,4]],"date-time":"2020-12-04T06:32:56Z","timestamp":1607063576000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":22,"title":["Iron Supplementation Interferes With Immune Therapy of Murine Mammary Carcinoma by Inhibiting Anti-Tumor T Cell Function"],"prefix":"10.3389","volume":"10","author":[{"given":"Piotr","family":"Tymoszuk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manfred","family":"Nairz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natascha","family":"Brigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Verena","family":"Petzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Heeke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Kircher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natascha","family":"Hermann-Kleiter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Klepsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Theurl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fcnter","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christa","family":"Pfeifhofer-Obermair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,12,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.cell.2010.06.028","article-title":"Two to tango: regulation of Mammalian iron metabolism","volume":"142","author":"Hentze","year":"2010","journal-title":"Cell"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1104742","article-title":"Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization","volume":"306","author":"Nemeth","year":"2004","journal-title":"Science"},{"key":"B3","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.bbagen.2011.10.013","article-title":"Regulation of iron transport and the role of transferrin","volume":"1820","author":"Gkouvatsos","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2019.224899","article-title":"Transferrin receptor 1-mediated iron uptake plays an essential role in hematopoiesis","volume":"105","author":"Wang","year":"2019","journal-title":"Haematologica"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-04-1086","article-title":"Transferrin receptor 1 is differentially required in lymphocyte development","volume":"102","author":"Ned","year":"2003","journal-title":"Blood"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3465","article-title":"A missense mutation in TFRC, encoding transferrin receptor 1, causes combined immunodeficiency","volume":"48","author":"Jabara","year":"2016","journal-title":"Nat Genet"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2013.09.001","article-title":"The complex interplay of iron metabolism, reactive oxygen species, and reactive nitrogen species: insights into the potential of various iron therapies to induce oxidative and nitrosative stress","volume":"65","author":"Koskenkorva-Frank","year":"2013","journal-title":"Free Radic Biol Med"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2007.03.010","article-title":"Intracellular labile iron","volume":"40","author":"Breuer","year":"2008","journal-title":"Int J Biochem Cell Biol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.imbio.2014.09.010","article-title":"\u2018Ride on the ferrous wheel\u2019\u2013the cycle of iron in macrophages in health and disease","volume":"220","author":"Nairz","year":"2015","journal-title":"Immunobiology"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2014.112813","article-title":"The role of inflammation, iron, and nutritional status in cancer-related anemia: results of a large, prospective, observational study","volume":"100","author":"Maccio","year":"2015","journal-title":"Haematologica"},{"key":"B11","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1182\/blood-2018-06-856500","article-title":"Anemia of inflammation","volume":"133","author":"Weiss","year":"2019","journal-title":"Blood"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1080\/01635581.2018.1460685","article-title":"Biological and Immunological Aspects of Iron Deficiency Anemia in Cancer Development: A Narrative Review","volume":"70","author":"Zohora","year":"2018","journal-title":"Nutr Cancer"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/0008-8749(91)90336-A","article-title":"Role of iron in T cell activation: TH1 clones differ from TH2 clones in their sensitivity to inhibition of DNA synthesis caused by IgG Mabs against the transferrin receptor and the iron chelator deferoxamine","volume":"134","author":"Thorson","year":"1991","journal-title":"Cell Immunol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/0167-5699(95)80034-4","article-title":"Linkage of cell-mediated immunity to iron metabolism","volume":"16","author":"Weiss","year":"1995","journal-title":"Immunol Today"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2018.00549","article-title":"Iron in the Tumor Microenvironment-Connecting the Dots","volume":"8","author":"Pfeifhofer-Obermair","year":"2018","journal-title":"Front Oncol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-11-1870","article-title":"An iron regulatory gene signature predicts outcome in breast cancer","volume":"71","author":"Miller","year":"2011","journal-title":"Cancer Res"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdm593","article-title":"Changes in breast cancer incidence and mortality in middle-aged and elderly women in 28 countries with Caucasian majority populations","volume":"19","author":"Hery","year":"2008","journal-title":"Ann Oncol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2020.100860","article-title":"Iron: The cancer connection","volume":"100860","author":"Torti","year":"2020","journal-title":"Mol Aspects Med"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23448","article-title":"HFE C282Y homozygotes are at increased risk of breast and colorectal cancer","volume":"51","author":"Osborne","year":"2010","journal-title":"Hepatology"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2011.228","article-title":"Modulation of Wnt\/beta-catenin signaling and proliferation by a ferrous iron chelator with therapeutic efficacy in genetically engineered mouse models of cancer","volume":"31","author":"Coombs","year":"2012","journal-title":"Oncogene"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2008.02.038","article-title":"Redox signaling and cancer: the role of \u201clabile\u201d iron","volume":"266","author":"Galaris","year":"2008","journal-title":"Cancer Lett"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/S0891-5849(02)00772-4","article-title":"Molecular bases of cellular iron toxicity","volume":"32","author":"Eaton","year":"2002","journal-title":"Free Radic Biol Med"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2007.02.001","article-title":"Cancer immunosurveillance, immunoediting and inflammation: independent or interdependent processes","volume":"19","author":"Bui","year":"2007","journal-title":"Curr Opin Immunol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.2310\/7200.2008.0016","article-title":"Breast cancer and the immune system","volume":"6","author":"Standish","year":"2008","journal-title":"J Soc Integr Oncol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/bcr1746","article-title":"Inflammation and breast cancer. Balancing immune response: crosstalk between adaptive and innate immune cells during breast cancer progression","volume":"9","author":"DeNardo","year":"2007","journal-title":"Breast Cancer Res"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-019-0220-6","article-title":"Helper T cell differentiation","volume":"16","author":"Saravia","year":"2019","journal-title":"Cell Mol Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-08-3485","article-title":"NK-cell activation by LIGHT triggers tumor-specific CD8+ T-cell immunity to reject established tumors","volume":"107","author":"Fan","year":"2006","journal-title":"Blood"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/S0960-9776(11)70298-3","article-title":"Immunity and autoimmunity: revising the concepts of response to breast cancer","volume":"20","author":"Curigliano","year":"2011","journal-title":"Breast"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1086\/516481","article-title":"Iron overload alters innate and T helper cell responses to Candida albicans in mice","volume":"175","author":"Mencacci","year":"1997","journal-title":"J Infect Dis"},{"key":"B30","doi-asserted-by":"publisher","first-page":"e0124246","DOI":"10.1371\/journal.pone.0124246","article-title":"Lymphocyte gene expression signatures from patients and mouse models of hereditary hemochromatosis reveal a function of HFE as a negative regulator of CD8+ T-lymphocyte activation and differentiation in vivo","volume":"10","author":"Costa","year":"2015","journal-title":"PloS One"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-008-0564-y","article-title":"Double-faced cell-mediated immunity in beta-thalassemia major: stimulated phenotype versus suppressed activity","volume":"88","author":"Gharagozloo","year":"2009","journal-title":"Ann Hematol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1111\/ejh.12936","article-title":"Intracellular iron overload leading to DNA damage of lymphocytes and immune dysfunction in thalassemia major patients","volume":"99","author":"Shaw","year":"2017","journal-title":"Eur J Haematol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1002\/iid3.158","article-title":"The hemochromatosis protein HFE 20 years later: An emerging role in antigen presentation and in the immune system","volume":"5","author":"Reuben","year":"2017","journal-title":"Immun Inflammation Dis"},{"key":"B34","doi-asserted-by":"publisher","first-page":"102837","DOI":"10.1016\/j.critrevonc.2019.102837","article-title":"Recent update in the pathogenesis and treatment of chemotherapy and cancer induced anemia","volume":"145","author":"Abdel-Razeq","year":"2020","journal-title":"Crit Rev Oncol Hematol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019004017","article-title":"How I treat Cancer Anemia","volume":"136","author":"Gilreath","year":"2020","journal-title":"Blood"},{"key":"B36","article-title":"Distant metastasis from subcutaneously grown E0771 medullary breast adenocarcinoma","volume":"25","author":"Ewens","year":"2005","journal-title":"Anticancer Res"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-3963","article-title":"Doxorubicin plus interleukin-2 chemoimmunotherapy against breast cancer in mice","volume":"66","author":"Ewens","year":"2006","journal-title":"Cancer Res"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnutbio.2011.10.013","article-title":"High-fat diet causes iron deficiency via hepcidin-independent reduction of duodenal iron absorption","volume":"23","author":"Sonnweber","year":"2012","journal-title":"J Nutr Biochem"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V88.4.1501.bloodjournal8841501","article-title":"Evidence for a graft-versus-tumor effect in a patient treated with marrow ablative chemotherapy and allogeneic bone marrow transplantation for breast cancer","volume":"88","author":"Eibl","year":"1996","journal-title":"Blood"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1038\/sj.embor.7400422","article-title":"Of mice and men. When it comes to studying ageing and the means to slow it down, mice are not just small humans","volume":"6","author":"Demetrius","year":"2005","journal-title":"EMBO Rep"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/S1357-2725(99)00070-9","article-title":"The transferrin receptor: role in health and disease","volume":"31","author":"Ponka","year":"1999","journal-title":"Int J Biochem Cell Biol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagen.2011.07.014","article-title":"Non-transferrin bound iron: a key role in iron overload and iron toxicity","volume":"1820","author":"Brissot","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"B43","doi-asserted-by":"publisher","first-page":"e79870","DOI":"10.1371\/journal.pone.0079870","article-title":"Non-transferrin-bound iron (NTBI) uptake by T lymphocytes: evidence for the selective acquisition of oligomeric ferric citrate species","volume":"8","author":"Arezes","year":"2013","journal-title":"PloS One"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2014.00024","article-title":"Physiological implications of NTBI uptake by T lymphocytes","volume":"5","author":"Pinto","year":"2014","journal-title":"Front Pharmacol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.98867","article-title":"Classical and intermediate monocytes scavenge non-transferrin-bound iron and damaged erythrocytes","volume":"4","author":"Haschka","year":"2019","journal-title":"JCI Insight"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/0022-1759(94)90236-4","article-title":"Determination of lymphocyte division by flow cytometry","volume":"171","author":"Lyons","year":"1994","journal-title":"J Immunol Methods"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-018-0009-3","article-title":"An early history of T cell-mediated cytotoxicity","volume":"18","author":"Golstein","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-01-0160","article-title":"Hemoglobin levels correlate with interleukin-6 levels in patients with advanced untreated epithelial ovarian cancer: role of inflammation in cancer-related anemia","volume":"106","author":"Maccio","year":"2005","journal-title":"Blood"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.12.2051","article-title":"Randomized trial of intravenous iron supplementation in patients with chemotherapy-related anemia without iron deficiency treated with darbepoetin alpha","volume":"26","author":"Pedrazzoli","year":"2008","journal-title":"J Clin Oncol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-12-195651","article-title":"Regulation of iron homeostasis in anemia of chronic disease and iron deficiency anemia: diagnostic and therapeutic implications","volume":"113","author":"Theurl","year":"2009","journal-title":"Blood"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-007-0009-9","article-title":"Anaemia in patients with cancer: role of inflammatory activity on iron metabolism and severity of anaemia","volume":"24","author":"Jacober","year":"2007","journal-title":"Med Oncol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.10.4620","article-title":"Randomized, multicenter, controlled trial comparing the efficacy and safety of darbepoetin alpha administered every 3 weeks with or without intravenous iron in patients with chemotherapy-induced anemia","volume":"26","author":"Bastit","year":"2008","journal-title":"J Clin Oncol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.12-2-231","article-title":"Intravenous ferric gluconate significantly improves response to epoetin alfa versus oral iron or no iron in anemic patients with cancer receiving chemotherapy","volume":"12","author":"Henry","year":"2007","journal-title":"Oncologist"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.3800288","article-title":"Erythropoietin and erythropoietin receptor expression in human cancer","volume":"61","author":"Acs","year":"2001","journal-title":"Cancer Res"},{"key":"B55","article-title":"Importance of erythropoetin receptor expression in tumour tissue for the clinical course of breast cancer","volume":"30","author":"Volgger","year":"2010","journal-title":"Anticancer Res"},{"key":"B56","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.immuni.2011.01.002","article-title":"Erythropoietin contrastingly affects bacterial infection and experimental colitis by inhibiting nuclear factor-kappaB-inducible immune pathways","volume":"34","author":"Nairz","year":"2011","journal-title":"Immunity"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.127428","article-title":"Erythropoietin inhibits SGK1-dependent TH17 induction and TH17-dependent kidney disease","volume":"5","author":"Donadei","year":"2019","journal-title":"JCI Insight"},{"key":"B58","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1200\/JCO.2010.30.3644","article-title":"Phase III, randomized study of the effects of parenteral iron, oral iron, or no iron supplementation on the erythropoietic response to darbepoetin alfa for patients with chemotherapy-associated anemia","volume":"29","author":"Steensma","year":"2011","journal-title":"J Clin Oncol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2014.07.029","article-title":"Disordered hepcidin-ferroportin signaling promotes breast cancer growth","volume":"26","author":"Zhang","year":"2014","journal-title":"Cell Signal"},{"key":"B60","doi-asserted-by":"publisher","first-page":"e2307","DOI":"10.1038\/cddis.2016.208","article-title":"Ferroptosis is induced following siramesine and lapatinib treatment of breast cancer cells","volume":"7","author":"Ma","year":"2016","journal-title":"Cell Death Dis"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1002\/phar.1729","article-title":"A Randomized Noninferiority Trial of Intravenous Iron Isomaltoside versus Oral Iron Sulfate in Patients with Nonmyeloid Malignancies and Anemia Receiving Chemotherapy: The PROFOUND Trial","volume":"36","author":"Birgegard","year":"2016","journal-title":"Pharmacotherapy"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201242505","article-title":"Lapatinib and doxorubicin enhance the Stat1-dependent antitumor immune response","volume":"43","author":"Hannesdottir","year":"2013","journal-title":"Eur J Immunol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2016.06.001","article-title":"Resistance Mechanisms to Immune-Checkpoint Blockade in Cancer: Tumor-Intrinsic and -Extrinsic Factors","volume":"44","author":"Pitt","year":"2016","journal-title":"Immunity"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.4161\/onci.21335","article-title":"Targeting PD-1\/PD-L1 interactions for cancer immunotherapy","volume":"1","author":"Zitvogel","year":"2012","journal-title":"Oncoimmunology"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-13-0127","article-title":"PD-L1 expression in triple-negative breast cancer","volume":"2","author":"Mittendorf","year":"2014","journal-title":"Cancer Immunol Res"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1172\/JCI96313","article-title":"Spatially distinct tumor immune microenvironments stratify triple-negative breast cancers","volume":"129","author":"Gruosso","year":"2019","journal-title":"J Clin Invest"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1111\/tbj.13112","article-title":"PD-L1 expression and CD8-positive T cells are associated with favorable survival in HER2-positive invasive breast cancer","volume":"24","author":"Hou","year":"2018","journal-title":"Breast J"},{"key":"B68","doi-asserted-by":"publisher","first-page":"e0196033","DOI":"10.1371\/journal.pone.0196033","article-title":"T cell mediated immunity after combination therapy with intralesional PV-10 and blockade of the PD-1\/PD-L1 pathway in a murine melanoma model","volume":"13","author":"Liu","year":"2018","journal-title":"PloS One"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-019-0432-4","article-title":"Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial","volume":"25","author":"Voorwerk","year":"2019","journal-title":"Nat Med"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1172\/JCI67008","article-title":"PD-L1 blockade synergizes with IL-2 therapy in reinvigorating exhausted T cells","volume":"123","author":"West","year":"2013","journal-title":"J Clin Invest"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1002\/1521-4141(200203)32:3<634::AID-IMMU634>3.0.CO;2-9","article-title":"PD-1:PD-L inhibitory pathway affects both CD4(+) and CD8(+) T cells and is overcome by IL-2","volume":"32","author":"Carter","year":"2002","journal-title":"Eur J Immunol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-020-03931-9","article-title":"Evaluation of regulatory T cells frequency and FoxP3\/GDF-15 gene expression in beta-thalassemia major patients with and without alloantibody; correlation with serum ferritin and folate levels","volume":"99","author":"Shokrgozar","year":"2020","journal-title":"Ann Hematol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2017.03.004","article-title":"Disturbances in iron homeostasis result in accelerated rejection after experimental heart transplantation","volume":"36","author":"Resch","year":"2017","journal-title":"J Heart Lung Transplant"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.3390\/nu11081758","article-title":"Prevention of Adult Colitis by Oral Ferric Iron in Juvenile Mice Is Associated with the Inhibition of the Tbet Promoter Hypomethylation and Gene Overexpression","volume":"11","author":"Ettreiki","year":"2019","journal-title":"Nutrients"},{"key":"B75","article-title":"Iron modulates interferon-gamma effects in the human myelomonocytic cell line THP-1","volume":"20","author":"Weiss","year":"1992","journal-title":"Exp Hematol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.0802420","article-title":"Pathways for the regulation of interferon-gamma-inducible genes by iron in human monocytic cells","volume":"74","author":"Oexle","year":"2003","journal-title":"J Leukoc Biol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2020.584477\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,4]],"date-time":"2020-12-04T06:32:59Z","timestamp":1607063579000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2020.584477\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,4]]},"references-count":76,"alternative-id":["10.3389\/fonc.2020.584477"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2020.584477","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,4]]},"article-number":"584477"}}